FindMyKOL
Clinical trialNCT03266692TerminatedPhase 1Interventional

Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma

SponsorCogent Biosciences, Inc.Enrollment15Multiple MyelomaMultiple Myeloma in RelapseRefractory Multiple Myeloma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a phase 1, multi-center, single-arm, open-label study evaluating the safety, tolerability, and anti-myeloma activity of ACTR087 (an autologous T cell product) in combination with SEA-BCMA (a monoclonal antibody) in subjects with relapsed or refractory Multiple Myeloma.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mayo Clinic

    Phoenix, Arizona, United States

  • Mayo Clinic

    Jacksonville, Florida, United States

  • Indiana Blood and Marrow Transplantation

    Indianapolis, Indiana, United States

  • Tufts Medical Center

    Boston, Massachusetts, United States

  • Ohio State University Wexner Medical Center

    Columbus, Ohio, United States

  • Baylor Scott & White

    Dallas, Texas, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

ACTR087SEA-BCMA
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Feb 2018
Primary completion
1 Oct 2019
Completion
1 Oct 2019
Last update posted
30 Mar 2020
Registered enrollment
15
Registry id
NCT03266692
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.